These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2866611)

  • 1. Effect of carteolol, indenolol and metoprolol on the thyroid hormone of hyperthyroid patients.
    Yamamoto M; Sakurada T; Yoshida K; Kaise K; Kaise N; Fukazawa H; Suzuki M; Nomura T; Itagaki Y; Saito S
    Tohoku J Exp Med; 1985 Aug; 146(4):385-90. PubMed ID: 2866611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients.
    Pfannenstiel P; Rummeny E; Baew-Christow T; Bux B; Cordes M; Adam W; Panitz N; Pabst J; Disselhoff G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S100-5. PubMed ID: 2439779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
    Taddei S; Pedrinelli R; Salvetti A
    Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
    Zuccari G; Falcone A; Turba C
    Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
    Nilsson OR; Melander A; Tegler L
    Eur J Clin Pharmacol; 1980 Oct; 18(4):315-20. PubMed ID: 7439251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
    Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
    J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of indenolol on human airways.
    Zanon P; Bruschi C; Cerveri I; Rossi A; Karitinos P; Pamparana F
    Eur J Clin Pharmacol; 1985; 29(3):287-92. PubMed ID: 2866966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged administration of indenolol in hypertensive rats.
    Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response studies of indenolol, a beta adrenoceptor blocker.
    Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking effect of single oral doses of carteolol.
    Stoll RW; Cavanaugh JH; MacLeod CM
    Clin Pharmacol Ther; 1981 Nov; 30(5):605-10. PubMed ID: 7297020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
    Poggesi L; Masotti G; Boddi M; Neri Serneri GG
    Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
    Perrild H; Hansen JM; Skovsted L; Christensen LK
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T; Ohnishi A; Sasaki T; Chiba K; Suganuma T; Kushida K
    Eur J Clin Pharmacol; 1983; 25(6):749-57. PubMed ID: 6141053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats.
    Yamashita K; Ohta H; Uchida S; Shigematsu K; Ohkubo T; Niwa M; Ozaki M
    J Pharmacobiodyn; 1990 Jan; 13(1):64-9. PubMed ID: 1971305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.
    Rassu S; Masala A; Alagna S; Rovasio PP; Langer M
    J Endocrinol Invest; 1982; 5(1):39-41. PubMed ID: 7096914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
    Tominaga M; Matsumori A; Okada I; Yamada T; Kawai C
    Circulation; 1991 Jun; 83(6):2021-8. PubMed ID: 1674900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
    Merli IP; Levenson J; Filitti V; Simon A
    Clin Pharmacol Ther; 1989 Dec; 46(6):686-92. PubMed ID: 2689046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.